Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 6/20 | 0.48 |
| ▸ | CA1 | P00915 | 6/20 | 0.48 |
| ▸ | CA2 | P00918 | 6/20 | 0.48 |
| ▸ | CA9 | Q16790 | 6/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CHAT | P28329 | 3/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | HPGDS | O60760 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.42 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.42 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | TXN | P10599 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2204687 | 1.00 | ENPP2 (0.49) | ENPP2CA12CA1CA2CA9 | |
| SCHEMBL11732259 | 0.99 | ENPP2 (0.48) | ENPP2CA12CA1CA2CA9 | |
| SCHEMBL2220503 | 0.99 | ENPP2 (0.48) | ENPP2CA12CA1CA2CA9 | |
| Calcium SCHEMBL2206379 | 0.99 | ENPP2 (0.48) | ENPP2CA12CA1CA2CA9 | |
| SCHEMBL2220482 | 0.97 | ENPP2 (0.47) | ENPP2CA12CA1CA2CA9 | |
| SCHEMBL16258799 | 0.95 | ENPP2 (0.45) | ENPP2CA12CA1CA2CA9 | |
| SCHEMBL16258775 | 0.94 | ENPP2 (0.44) | ENPP2CA12CA1CA2CA9 | |
| SCHEMBL15258072 | 0.93 | ENPP2 (0.46) | ENPP2CA12CA1CA2CA9 | |
| SCHEMBL2205601 | 0.92 | CA12 (0.47) | ENPP2CA12CA1CA2CA9 | |
| SCHEMBL18043806 | 0.92 | CA12 (0.47) | ENPP2CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2571973-B1 | OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & CO (US) | 2020-04-01 | — | — | EP | disclosed |
| EP-2716466-B1 | THERMAL RECORDING MATERIAL CONTAINING STILBENE DISULPHONIC ACID FLUORESCENT WHITENING AGENT | RICOH IND FRANCE SAS (FR) | 2016-09-14 | — | — | EP | disclosed |
| US-9376405-B2 | Bis-(triazinylamino)-stilbene derivatives | CLARIANT INTERNATIONAL LTD (CH) | 2016-06-28 | — | — | US | disclosed |
| EP-2518058-B1 | Novel bis-(triazinylamino)-stilbene derivatives | CLARIANT INT LTD (CH) | 2014-10-29 | — | — | EP | disclosed |
| US-8740997-B2 | Optical brighteners and compositions comprising the same | MILLIKEN & COMPANY (US) | 2014-06-03 | — | — | US | disclosed |
| US-20140142305-A1 | NOVEL BIS-(TRIAZINYLAMINO)-STILBENE DERIVATIVES | CLARIANT INTERNATIONAL LTD (CH) | 2014-05-22 | — | — | US | disclosed |
| US-20130281347-A1 | OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & COMPANY | 2013-10-24 | — | — | US | disclosed |
| US-8454711-B2 | Optical brighteners and compositions comprising the same | MILLIKEN & COMPANY (US) | 2013-06-04 | — | — | US | disclosed |
| US-20120329699-A1 | OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & COMPANY (US) | 2012-12-27 | — | — | US | disclosed |
| US-8262744-B2 | Optical brighteners and compositions comprising the same | MILLIKEN & COMPANY (US) | 2012-09-11 | — | — | US | disclosed |
| EP-2345541-B1 | Thermosensitive recording material and image recording method | RICOH CO LTD (JP) | 2012-08-29 | — | — | EP | disclosed |
| WO-2011146604-A2 | OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & COMPANY (US) | 2011-11-24 | — | — | WO | disclosed |
| US-20110287999-A1 | OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & COMPANY | 2011-11-24 | — | — | US | disclosed |
| EP-2345541-A2 | Thermosensitive recording material and image recording method | Ricoh Company, Ltd. (JP) | 2011-07-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142305-A1 | NOVEL BIS-(TRIAZINYLAMINO)-STILBENE DERIVATIVES | TSN, SMARCB1, TXLNA | ENPP2 1653/4885CA12 3610/4885CA1 4714/4885 |
| US-20110287999-A1 | OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME | DBN1, AOC1, RARB | ENPP2 754/4885CA12 3343/4885CA1 3242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.